Magellan Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.1M Buy
570,409
+19,628
+4% +$1.72M 1.1% 31
2026
Q1
$49.8M Sell
550,781
-85,953
-13% -$7.89M 0.65% 42
2025
Q4
$57.3M Buy
636,734
+36,609
+6% +$3.47M 0.7% 36
2025
Q3
$59.1M Buy
600,125
+94,224
+19% +$9.34M 0.7% 36
2025
Q2
$46.1M Buy
505,901
+72,613
+17% +$7.02M 0.53% 33
2025
Q1
$49M Buy
433,288
+38,914
+10% +$4.16M 0.6% 34
2024
Q4
$41.7M Buy
394,374
+119,869
+44% +$12.9M 0.46% 35
2024
Q3
$29.6M Buy
+274,505
New +$30M 0.3% 45
2021
Q1
Sell
-264
Closed -$39K 113
2020
Q4
$39K Hold
264
﹤0.01% 106
2020
Q3
$35K Buy
+264
New +$34.5K ﹤0.01% 78

Other funds holding ZBH

Magellan Asset Management's ZBH Position: Q2 2026 in Review

Magellan Asset Management increased its Zimmer Biomet (ZBH) stake by 3.6% in Q2 2026, buying an estimated $1.72M and bringing the position to 570,409 shares worth $49.1M. The position accounts for 1.1% of the portfolio, ranked #31.

Magellan Asset Management first reported a position in ZBH in Q3 2020 and has held it in 10 quarters since. The position peaked at $59.1M in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Magellan Asset Management held 570,409 shares of Zimmer Biomet worth $49.1M as of Q2 2026.
  • Magellan Asset Management bought 19,628 Zimmer Biomet shares in Q2 2026, an estimated $1.72M.
  • Zimmer Biomet made up 1.1% of Magellan Asset Management's portfolio in Q2 2026, its #31 holding.
  • Magellan Asset Management first reported a position in Zimmer Biomet in Q3 2020 and has held it in 10 quarters since.
  • Magellan Asset Management's Zimmer Biomet position peaked at $59.1M in Q3 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Magellan Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.